HSKA earnings
Heska Corporation (HSKA) earnings releases and earnings dates - real-time wire coverage of every quarterly report.
Recent earnings items
- Heska Corporation Reports Fourth Quarter and Full Year 2022 ResultsFull Year Sales $257.3 Million, Full Year Gross Margin Up 150 Basis Points to 43.2% Full Year North America Lab Consumables Sales Up 8.7%, Total Active Subscriptions Up 18% LOVELAND, Colo., Feb. 28, 2023 /PRNewswire/ -- Heska Corporation (NASDAQ:HSKA, ", Heska", or ", Company", ))), a leading global provider of advanced veterinary diagnostic and specialty products, reported financial results in two segments (North America and International) for its fourth quarter and full year ended December 31, 2022. Fourth Quarter and Full Year 2022 and Year Over Year ("YOY") Metrics $ in mi
- Heska Fourth Quarter and Full Year 2022 Financial Results and Earnings Call Scheduled for February 28, 2023LOVELAND, Colo., Feb. 8, 2023 /PRNewswire/ -- Heska Corporation (NASDAQ:HSKA, ", Heska", or the ", Company", ))), a leading global provider of advanced veterinary diagnostic and specialty solutions, will report its fourth quarter and full year 2022 financial performance in a press release before the market opens on Tuesday, February 28, 2023. The Company will also host an earnings call at 9 a.m. MT / 11 a.m. ET to discuss the results. To access the conference call: From within the United States, please dial 1-877-41-6152From outside of the United States, please dial 1-201-389-
- Heska Corporation Completes Acquisition of LightDeck DiagnosticsLOVELAND, Colo., Jan. 3, 2023 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty products and solutions, today announced the completion of acquisition of 100% of the shares of MBio Diagnostics, Inc. d/b/a LightDeck Diagnostics ("LightDeck"), a pioneer in planar waveguide fluorescence immunoassay diagnostics with strong manufacturing capabilities and research and development expertise (the "Acquisition"). The Acquisition, which was first announced on September 12, 2022, represent
- Heska Corporation Reports Third Quarter 2022 ResultsNorth America Point of Care Lab Consumables up 11.4%, Consolidated Gross Margin up 180 bps LOVELAND, Colo., Nov. 8, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ:HSKA, ", Heska", or the ", Company", ))), a leading global provider of advanced veterinary diagnostic and specialty solutions, reported financial results in two segments (North America and International) for its third quarter ended September 30, 2022. In this release, Point of Care is "POC", Pharmaceuticals, Vaccines and Diagnostics is "PVD", Other Vaccines and Pharmaceuticals is "OVP", and basis points is "bps". Thi
- Heska Third Quarter 2022 Financial Results and Earnings Call Scheduled for November 8, 2022LOVELAND, Colo., Oct. 18, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ:HSKA, ", Heska", or the ", Company", ))), a leading global provider of advanced veterinary diagnostic and specialty solutions, will report its third quarter 2022 financial performance in a press release before the market opens on Tuesday, November 8, 2022. The Company will also host an earnings call at 9 a.m. MT / 11 a.m. ET to discuss the results. To access the conference call: From within the United States, please dial 1-800-239-9838From outside of the United States, please dial 1-323-794-2551Reference
- Heska to Acquire LightDeck Diagnostics to Invest in Manufacturing Capabilities and Accelerate Research and Development EffortsLOVELAND, Colo., Sept. 12, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ:HSKA, ", Heska", or the ", Company", ))), a leading global provider of advanced veterinary diagnostic and specialty solutions, announced today that the Company has entered a definitive agreement to acquire 100% of the share capital of MBio Diagnostics, Inc. d/b/a LightDeck Diagnostics ("LightDeck"), a pioneer in innovative planar waveguide fluorescence immunoassay diagnostics with strong manufacturing and specialized production capabilities (the "Acquisition"). Founded in 2009 and headquartered in Boul
- Heska Corporation Reports Second Quarter 2022 ResultsLOVELAND, Colo., Aug. 8, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ:HSKA, ", Heska", or the ", Company", ))), a leading global provider of advanced veterinary diagnostic and specialty solutions, reported financial results in two segments (North America and International) for its second quarter ended June 30, 2022. In this release, Point of Care is "POC", Pharmaceuticals, Vaccines and Diagnostics is "PVD", Other Vaccines and Pharmaceuticals is "OVP", and basis points is "bps". Second Quarter 2022 and Year Over Year ("YOY") Metrics $ in millions except Earnings Per Share (
- Heska Second Quarter 2022 Financial Results and Earnings Call Scheduled for August 8, 2022LOVELAND, Colo., July 20, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ:HSKA, ", Heska", or the ", Company", ))), a leading global provider of advanced veterinary diagnostic and specialty solutions, will report its second quarter 2022 financial performance in a press release before the market opens on Monday, August 8, 2022. The Company will also host an earnings call at 9 a.m. MT / 11 a.m. ET to discuss the results. To access the conference call: From within the United States, please dial 1-800-289-0720 From outside of the United States, please dial 1-323-701-0160 R
- Heska Corporation Reports First Quarter 2022 ResultsQuarterly Revenue Up 7% (10% in Constant Currency), Gross Margin Up 290 bps North America POC Lab Consumables Up 10%, Full Year Outlook Reiterated LOVELAND, Colo., May 9, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ:HSKA, ", Heska", or the ", Company", ))), a leading global provider of advanced veterinary diagnostic and specialty solutions, reported financial results in two segments (North America and International) for its first quarter ended March 31, 2022. First Quarter 2022 and Year Over Year ("YOY") Metrics $ in millions except Earnings Per Share ("EPS") Q1 ($) Q1 (%) Y
- Heska First Quarter 2022 Financial Results and Earnings Call Scheduled for May 9, 2022LOVELAND, Colo., April 18, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ:HSKA, ", Heska", or the ", Company", ))), a leading global provider of advanced veterinary diagnostic and specialty solutions, will report its first quarter 2022 financial performance in a press release before the market opens on Monday, May 9, 2022. The Company will also host an earnings call at 9 a.m. MT / 11 a.m. ET to discuss the results. To access the conference call: From within the United States, please dial 1-800-239-9838 From outside of the United States, please dial 1-323-794-2551 Refe
- Heska Corporation Reports Fourth Quarter and Full Year 2021 ResultsLOVELAND, Colo., Feb. 28, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ:HSKA, ", Heska", or ", Company", ))), a leading global provider of advanced veterinary diagnostic and specialty products, reported financial results in two segments (North America and International) for its fourth quarter and full year ended December 31, 2021. In this release, Point of Care is "POC", Pharmaceuticals, Vaccines and Diagnostics is "PVD", Other Vaccines and Pharmaceuticals is "OVP", scil animal care company GmbH is "scil", and basis points is "bps". Report Highlights Full year active subscrip
- Heska Fourth Quarter and Full Year 2021 Financial Results and Earnings Call Scheduled for February 28, 2022LOVELAND, Colo., Jan. 31, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ:HSKA, ", Heska", or the ", Company", ))), a leading global provider of advanced veterinary diagnostic and specialty products and solutions, will report its fourth quarter and full year 2021 financial performance in a press release before the market opens on Monday, February 28, 2022. The Company will also host an earnings call at 9 a.m. MT / 11 a.m. ET to discuss the results. To access the conference call:From within the United States, please dial 1-800-239-9838From outside of the United States, please di
- Heska Corporation Completes Acquisition of VetZ GmbH to Become European Leader in Practice Management Software SolutionsLOVELAND, Colo., Jan. 3, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ:HSKA, ", Heska", or the ", Company", ))), a leading global provider of advanced veterinary diagnostic and specialty products and solutions, today announced the completion of the acquisition of VetZ GmbH ("VetZ"), a European trailblazer in veterinary practice information management software solutions ("PIMS") (the "Acquisition"). The Acquisition, which was first announced on November 2, 2021, represents a key milestone in the Company's strategic plan. Headquartered in Germany, VetZ has been a leader since its founding in 1997, providing powerful, easy-to-use and fully integrated software solutions for better workflow, com
- Heska Corporation Reports Third Quarter 2021 ResultsLOVELAND, Colo., Nov. 4, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ:HSKA, ", Heska", or ", Company", ))), a leading provider of advanced veterinary diagnostic and specialty products, reported financial results in two segments (North America and International) for its third quarter ended September 30, 2021. In this release, Point of Care is "POC", Pharmaceuticals, Vaccines and Diagnostics is "PVD", Other Vaccines and Pharmaceuticals is "OVP", contract subscription value is "CSV", practice information management software is "PIMS", Biotech Laboratories U.S.A. LLC is "Biotech", BiEsseA Laboratorio Veterinario Srl is "BiEsseA", Lacuna Diagnostics, Inc. is "Lacuna", and scil animal care compa
- Heska Corporation to Acquire VetZ GmbH, European Leader in Practice Information Management Software SolutionsLOVELAND, Colo., Nov. 2, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ:HSKA, ", Heska", or the ", Company", ))), a leading global provider of advanced veterinary diagnostic and specialty products, announced today that the Company has entered a definitive agreement (the "Agreement") to acquire 100% of VetZ GmbH ("VetZ"), a European leader in veterinary practice information management software solutions ("PIMS") (such transaction, the "Acquisition"). Founded in 1997 and headquartered in Isernhagen, Germany, VetZ has created powerful, easy-to-use and fully integrated software so
- Heska Third Quarter 2021 Financial Results and Earnings Call Scheduled for November 4, 2021LOVELAND, Colo., Oct. 12, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ:HSKA, ", Heska", or the ", Company", ))), a leading provider of advanced veterinary diagnostic and specialty products, will report its third quarter 2021 financial performance in a press release before the market opens on Thursday, November 4, 2021. The Company will also host an earnings call at 9 a.m. MT / 11 a.m. ET to discuss the results. To access the conference call: From within the United States, please dial 1-888-394-8218 From outside of the United States, please dial 1-323-701-0225 Reference Conference ID: 2365183 The earnings call will be webcast live from the Company's investor relations website at
- Heska Corporation Reports Second Quarter 2021 ResultsLOVELAND, Colo., Aug. 3, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ:HSKA, ", Heska", or ", Company", ))), a leading provider of advanced veterinary diagnostic and specialty products, reported financial results in two segments (North America and International) for its second quarter ended June 30, 2021. Point of Care is "POC" and scil animal care company GmbH is "scil" in this release. Second Quarter 2021 and Year Over Year ("YOY") Metrics $ in millions except Earnings Per Share ("EPS") Q2 ($) Q2 (%) YOY Consolidated Revenue $64.9 42.0% North America Revenue $40.5 39.9% Int